We also compared the differences in expression levels of TEX marker genes (HAVCR2, TIGIT, CTLA4, LAG3, and PD1) and the putative tumor stem cell marker genes (CD44 and PROM1) between high and low TEXSRGs-score groups in clinical tumor samples using qRT-PCR. This evidence concerns the gene PROM1 and neoplasm.